2019 Global NAFLD prevalence: a systematic review and meta-analysis
Background & Aims The increasing rates of obesity and type 2 diabetes mellitus may lead to
increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine …
increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine …
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
MH Le, DM Le, TC Baez, Y Wu, T Ito, EY Lee… - Journal of …, 2023 - Elsevier
Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) is
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial
Innovative non-pharmacological lifestyle strategies to treat non-alcoholic fatty liver disease
(NAFLD) are critically needed. This study compared the effects of alternate day fasting (ADF) …
(NAFLD) are critically needed. This study compared the effects of alternate day fasting (ADF) …
Metabolic syndrome and sarcopenia
H Nishikawa, A Asai, S Fukunishi, S Nishiguchi… - Nutrients, 2021 - mdpi.com
Skeletal muscle is a major organ of insulin-induced glucose metabolism. In addition, loss of
muscle mass is closely linked to insulin resistance (IR) and metabolic syndrome (Met-S) …
muscle mass is closely linked to insulin resistance (IR) and metabolic syndrome (Met-S) …
[HTML][HTML] Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver
Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences
S Hong, KM Choi - International journal of molecular sciences, 2020 - mdpi.com
The prevalence of sarcopenic obesity is increasing worldwide, particularly amongst aging
populations. Insulin resistance is the core mechanism of sarcopenic obesity and is also …
populations. Insulin resistance is the core mechanism of sarcopenic obesity and is also …
Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors
The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising. NAFLD/nonalcoholic
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …
[HTML][HTML] Non-alcoholic fatty liver disease: Definition and subtypes
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …
[HTML][HTML] Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations
Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial
pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an …
pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an …
[HTML][HTML] KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …